Navigation Links
Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
Date:12/7/2010

a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal.  The Company's lead preclinical program is the Neo-Kidney Augment™, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure.  Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment™ for the treatment of neurogenic bladder.  Tengion has worldwide rights to its product candidates. For more information, please visit www.tengion.com.

Forward-Looking Statements

Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to the Company's: (i) plans to develop and commercialize its product candidates, including the Neo- Kidney Augment and the Neo-Urinary Conduit; and (ii) expectations regarding ongoing and planned preclinical studies and clinical trials. Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company will be able to obtain the capital it needs to develop its product candidates or continue as a going concern; (ii) the Company will be able to successfully enroll patients in its clinical trials, including its Phase I clinical trial for the Neo-Urinary Conduit; (iii) patients enrolled in the Company's clinical t
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
6. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
7. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
10. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
11. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... and LONDON , Sept. 30, ... MediciGlobal Ltd. announces its major milestone: ... community which caters to patients, families and caregivers, was ... tests and evolving treatments for Alzheimer,s disease. It also ... daily postings. Alzheimer,s ranks as the leading ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014 Headquartered ... (OTC: GWPC) is a diversified company comprised of several ... of advanced technology and the proven expertise of its ... health and wellness. WholeHealth Products, line of more than ... healthcare centers, and its more than 8 retail consumer ...
(Date:9/30/2014)... N.Y. , Sept. 30, 2014  Millennium ... Millennium Medical Devices, has executed a sales, marketing ... Florida based provider of ... Accountable Care Organizations (ACOs) and hospitals through a ... serves over 10,400 active Physician Purchasing Accounts that ...
Breaking Medicine Technology:MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 3
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
(Date:9/30/2014)... 2014 Bifidobacteria, the primary bacteria found ... diet, and stress, so a high Bifido probiotic can ... Ultimate Flora™ Men’s Complete contains 90 Billion ... Bifidobacteria strains to support a healthy large intestine (colon) ... and 32 billion cultures from 7 Lactobacillus strains to ...
(Date:9/30/2014)... in reducing the stigma associated with seeking help for ... but more improvement is still needed, according to a ... the Defense Department and the Veterans Health Administration to ... not seek needed care for mental health problems. ... treatment as a way to reduce stigma, according to ...
(Date:9/30/2014)... September 30, 2014 Healthcare advocates, patient ... National Association of Health Advocacy Consultants (#NAHAC) fifth annual ... (#NAHAC14) to be held October 30th - Nov. 1st, ... at NAHAC14: Standards and Best Practices for the Field ... a profession, advocates have needed a set of standards ...
(Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
Breaking Medicine News(10 mins):Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3
... a leader,in the development and marketing of disposable ... announced today that,BSSI has been purchased by Linden ... to Microflex(R), BSSI also owns MicroActive Corporation and,FoodHandler(R), ... leading supplier,of health and safety barrier products to ...
... and special initiatives encourage smokers to say ,I Quit, at The ... ... There,s some,ash-kicking, going on at the BODY WORLDS exhibit. Lung Cancer ... California,s,6-session Ash Kickers Quit Smoking Class and BODY WORLDS, I Quit ...
... Americans Have No Long Term Care Plans, WASHINGTON, ... long term care has on American families, the U.S. ... resolution proclaiming its,support for national Long Term Care Awareness ... one of the nation,s leading providers of,individual long term ...
... raising goal for United Way of ... ... Company,(NYSE: LLY ) chairman and chief executive officer Sidney Taurel ... Lilly,s,commitment to the agency,s 2008 fundraising campaign. For the United Way ...
... researchers find , TUESDAY, Nov. 6 (HealthDay News) -- ... of preclinical cardiovascular disease, U.S researchers report.. , Researchers ... women (who were free of cardiovascular disease at the ... intima media thickness (cIMT), a measure of the ...
... a mother with Alzheimers disease appear to be at higher risk ... according to a new study by NYU School of Medicine researchers. ... in this weeks online edition of the Proceedings of the National ... among cognitively normal people who have a father, a mother, or ...
Cached Medicine News:Health News:Microflex(R) Corporation Acquired by Linden and Edgewater 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 3Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 2Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 3Health News:Lilly Contributes $10.8 Million to United Way Annual Campaign 2Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3
For the quantitative in vitro determination of Alanine Aminotransferase (ALT) in serum and plasma....
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic Fibrosis ... cystic fibrosis genotyping. With validated performance criteria, ... will provide superior mutation coverage for carrier ... to diagnosis in newborns. ,The Tag-It™ ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: